Two Sigma Securities’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,900
Closed -$304K 1570
2024
Q3
$304K Sell
2,900
-3,100
-52% -$363K 0.01% 1735
2024
Q2
$853K Sell
6,000
-3,500
-37% -$404K 0.01% 1169
2024
Q1
$1.06M Buy
9,500
+4,600
+94% +$548K 0.01% 1102
2023
Q4
$635K Buy
4,900
+300
+7% +$41.3K 0.01% 1372
2023
Q3
$750K Sell
4,600
-9,500
-67% -$1.67M 0.01% 1234
2023
Q2
$2.58M Buy
14,100
+8,800
+166% +$1.27M 0.04% 499
2023
Q1
$706K Buy
+5,300
New +$623K 0.01% 1037

Other funds holding ACLS

Two Sigma Securities's ACLS Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Axcelis (ACLS) in Q2 2026: 3,412 shares worth $646K. The stake represents 0.06% of the portfolio and ranks #471 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ACLS as recently as Q4 2025.

Two Sigma Securities first reported a position in ACLS in Q3 2023 and has held it in 5 quarters since. The position peaked at $750K in Q4 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Two Sigma Securities held 3,412 shares of Axcelis worth $646K as of Q2 2026.
  • Axcelis was a new Two Sigma Securities position in Q2 2026.
  • Axcelis made up 0.06% of Two Sigma Securities's portfolio in Q2 2026, its #471 holding.
  • Two Sigma Securities first reported a position in Axcelis in Q3 2023 and has held it in 5 quarters since.
  • Two Sigma Securities's Axcelis position peaked at $750K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.